OTC Markets OTCQX - Delayed Quote USD

Covalon Technologies Ltd. (CVALF)

1.7200

0.0000

(0.00%)

At close: April 22 at 4:00:00 PM EDT

Covalon to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025

MISSISSAUGA, Ontario, April 17, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that they will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 4:30 pm (Local Time -PST).

Business Wire 5 days ago

CVALF
0.00%
Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome

MISSISSAUGA, Ontario, April 03, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company is pleased to announce the very positive outcome for the Company with regards to the April 2, 2025 tariff announcements by U.S. President Donald Trump.

Business Wire 19 days ago

CVALF
0.00%
Covalon Announces Voting Results from Fiscal 2024 Annual Meeting of Shareholders

MISSISSAUGA, Ontario, March 20, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the matters voted upon at its Fiscal 2024 Annual Meeting of Shareholders ("AGM") held March 19, 2025.

Business Wire last month

CVALF
0.00%
Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 19, 2025

MISSISSAUGA, Ontario, March 12, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 19, 2025 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting will include a presentation from Covalon’s recently appointed CEO, Brent Ashton, with a

Business Wire last month

CVALF
0.00%
Covalon Technologies First Quarter 2025 Earnings: EPS: CA$0.04 (vs CA$0.035 loss in 1Q 2024)

Covalon Technologies ( CVE:COV ) First Quarter 2025 Results Key Financial Results Revenue: CA$8.17m (up 75% from 1Q...

Simply Wall St. last month

CVALF
0.00%
Covalon Reports Fourth Consecutive Quarter of Year over Year Revenue Growth and Positive Earnings

MISSISSAUGA, Ontario, February 21, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 first quarter results for the period ended December 31, 2024 along with a number of important recent achievements and highlights.

Business Wire last month

CVALF
0.00%
Covalon Technologies Ltd. Named as a TSX Venture Exchange 2025 Top 50 Company

MISSISSAUGA, Ontario, February 19, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that it has been recognized by the TSX Venture Exchange (TSXV) as a 2025 Top 50 Company, an influential accomplishment honoring the top fifty performing companies on the TSXV over the past year.

Business Wire 2 months ago

CVALF
0.00%
Covalon Announces Conference Call to Discuss First Quarter Fiscal 2025 Financial Results

MISSISSAUGA, Ontario, February 14, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q1 Fiscal 2025 financial results on Friday, February 21, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Friday, February 21, 2025, at 8:30am ET.

Business Wire 2 months ago

CVALF
0.00%
Covalon Technologies Releases Statement on United States – Canada Trade Dispute

MISSISSAUGA, Ontario, February 03, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today released a statement on the tariffs announced by President Trump on Canadian imports.

Business Wire 2 months ago

CVALF
0.00%
Covalon Technologies Ltd. Selected as a 2025 OTCQX Best 50 Company

MISSISSAUGA, Ontario, February 03, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has been recognized as one of the 2025 OTCQX Best 50 companies, a prestigious award that honors the top-performing OTCQX companies of 2024. This recognition is based on total return and growth in average daily dollar volume over the past year. Covalon placed 4th overall in the rankings and was the top Medical

Business Wire 2 months ago

CVALF
0.00%
Covalon Technologies Ltd.'s (CVE:COV) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

With its stock down 12% over the past month, it is easy to disregard Covalon Technologies (CVE:COV). However, stock...

Simply Wall St. 3 months ago

CVALF
0.00%
Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results

MISSISSAUGA, Ontario, January 07, 2025--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 fourth quarter and year end results for the period ended September 30, 2024.

Business Wire 3 months ago

CVALF
0.00%
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2024 Financial Results

MISSISSAUGA, Ontario, December 19, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2024 financial results on Tuesday, January 7, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Tuesday, January 7, 2025, at 8:30am ET.

Business Wire 4 months ago

CVALF
0.00%
Investors in Covalon Technologies (CVE:COV) have seen strong returns of 200% over the past year

When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right stock...

Simply Wall St. 5 months ago

CVALF
0.00%
Covalon Technologies Highlights Compassionate Care Technologies at 2024 ANCC National Magnet Conference

MISSISSAUGA, Ontario, October 30, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), is pleased to announce its participation in the American Nurses Credentialing Center ("ANCC") National Magnet Conference® from Wednesday, October 30 to Saturday, November 1, 2024, in New Orleans, LA.

Business Wire 5 months ago

CVALF
0.00%
Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting

MISSISSAUGA, Ontario, September 27, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), is pleased to announce its participation in the 2024 Association for Vascular Access ("AVA") Annual Scientific Meeting. The event will take place from September 28 to 30 in Colorado. Founded in 1985, AVA’s multidisciplinary membership is dedicated to advancing research, providing education, and fostering collaboration to improve patient outcomes in vascular access. Covalon

Business Wire 6 months ago

CVALF
0.00%
Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver

VANCOUVER, BC / ACCESSWIRE / September 24, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VANCOUVER taking place on September 25-26, 2024, where 50 MicroCap public and private companies will be presenting at the Fairmont Waterfront ...

ACCESS Newswire 6 months ago

SSLCF

GHIFF

NWVCF
Covalon Announces Successful Warrant Redemption from 2019 Private Placement

MISSISSAUGA, Ontario, September 23, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that the directors of the Company (the "Insiders") have exercised a cumulative total of 852,700 common share purchase warrants ("warrants"), generating proceeds of approximately $1.7 million CAD. In addition to the Insiders, long-term shareholders exercised 1,875,800 warrants, generating proceeds of approximat

Business Wire 6 months ago

CVALF
0.00%
Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST

MISSISSAUGA, ON / ACCESSWIRE / September 19, 2024 / Covalon Technologies Ltd., ("Covalon"), (TSXV:COV)(OTCQX:CVALF), an advanced medical technologies company, today announced that it will be presenting and participating in meetings at the Planet MicroCap ...

ACCESS Newswire 6 months ago

CVALF
0.00%
Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference

MISSISSAUGA, Ontario, September 11, 2024--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the Association of Pediatric Hematology/Oncology Nurses (APHON) Annual 2024 Conference. The conference, taking place in Salt Lake City, Utah from September 11 to 13, is a premier event for pediatric hematology/oncology nursing professionals involved in patient care, education, case management, an

Business Wire 7 months ago

CVALF
0.00%

Performance Overview

Return	CVALF	S&P/TSX Composite index (^GSPTSE)
YTD	-23.56%	-1.28%
1-Year	+115.00%	+11.13%
3-Year	+4.88%	+14.72%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Covalon Technologies Ltd. (CVALF)

Covalon to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025

Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome

Covalon Announces Voting Results from Fiscal 2024 Annual Meeting of Shareholders

Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 19, 2025

Covalon Technologies First Quarter 2025 Earnings: EPS: CA$0.04 (vs CA$0.035 loss in 1Q 2024)

Covalon Reports Fourth Consecutive Quarter of Year over Year Revenue Growth and Positive Earnings

Covalon Technologies Ltd. Named as a TSX Venture Exchange 2025 Top 50 Company

Covalon Announces Conference Call to Discuss First Quarter Fiscal 2025 Financial Results

Covalon Technologies Releases Statement on United States – Canada Trade Dispute

Covalon Technologies Ltd. Selected as a 2025 OTCQX Best 50 Company

Covalon Technologies Ltd.'s (CVE:COV) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Covalon Announces Strong Fourth Quarter and Year End Fiscal 2024 Results

Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2024 Financial Results

Investors in Covalon Technologies (CVE:COV) have seen strong returns of 200% over the past year

Covalon Technologies Highlights Compassionate Care Technologies at 2024 ANCC National Magnet Conference

Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting

Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver

Covalon Announces Successful Warrant Redemption from 2019 Private Placement

Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST

Covalon Technologies Ltd. to Showcase Innovative Vascular Access Solutions at the Annual Association of Pediatric Hematology/Oncology Nurses Conference

Performance Overview